MedPath

Teres Bio, Inc.

🇺🇸United States
Ownership
Holding
Employees
-
Market Cap
-
Website

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: Vehicle
First Posted Date
2021-02-12
Last Posted Date
2022-07-26
Lead Sponsor
Teres Bio, Inc.
Target Recruit Count
63
Registration Number
NCT04753034
Locations
🇺🇸

Teres Bio Site 06, Pflugerville, Texas, United States

🇺🇸

Teres Bio Site 11, Wilmington, North Carolina, United States

🇺🇸

Teres Bio site 09, Saint Joseph, Missouri, United States

and more 9 locations
© Copyright 2025. All Rights Reserved by MedPath